Lisa Kallenbach, MD, MPA Johnson + Johnson Innovative Medicine
Lisa Kallenbach is a group medical director for U.S. medical affairs, CAR-T (chimeric antigen receptor T-cell therapy) at Johnson & Johnson Innovative Medicine. She is a subject matter expert in multiple myeloma and leads efforts to optimize care for patients treated with cilta-cel. An experienced hematologist and oncologist, prior to joining J&J she practiced at the Abramson Cancer Center at Penn Presbyterian Medical Center in Philadelphia. Lisa continues to work as a collaborator with Partners in Health in Rwanda, helping to educate and train internists providing cancer care at the Butaro Cancer Center of Excellence.
Lisa received her Doctor of Medicine from the Warren Alpert Medical School of Brown University and completed a fellowship in hematology/oncology at Tufts Medical Center in Boston. She received her Master of Public Administration from New York University and her Bachelor of Arts from the University of Pennsylvania. A returned Peace Corps volunteer, she served in Guinea-Bissau, West Africa.
See Lisa speak at the Annual Benefits Forum in Columbus, OH in April.